T

Threshold Pharmaceuticals

31 employees

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2001

Funding rounds raised

Total raised

$41M

from 11 investors over 11 rounds

T

Threshold Pharmaceuticals raised $15M on March 17, 2017

Investors: Cancer Prevention and Research Institute of Texas

T

Threshold Pharmaceuticals raised $20M on April 11, 2012

Investors: Merck Group

T

Threshold Pharmaceuticals raised $35M on October 7, 2009

Investors: Great Point Partners and Frazier Healthcare Partners

T

Threshold Pharmaceuticals raised $41M on January 14, 2004

Investors: Three Arch Partners, Morgenthaler, ProQuest Investments and Sofinnova Ventures, Russia technology fund

T

Threshold Pharmaceuticals raised $8.3M on August 28, 2002

Investors: Three Arch Partners, ProQuest Investments and Sofinnova Ventures, Russia technology fund

FAQ